N1-cyclohexyl-N1-methyl-1,4-butanediamine | 675137-98-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N1-cyclohexyl-N1-methyl-1,4-butanediamine
• 英文别名: N'-cyclohexyl-N'-methylbutane-1,4-diamine
• CAS: 675137-98-1
• 化学式: C₁₁H₂₄N₂
• 分子量: 184.325
• InChiKey: LRXOKPBAYQVONA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-{[(tert-butoxycarbonyl)(1H-imidazol-2-ylmethyl)amino]methyl}benzoic acid 、 N1-cyclohexyl-N1-methyl-1,4-butanediamine 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 氯仿 为溶剂， 反应 16.0h， 生成 {4-[4-(cyclohexyl-methylamino)-butylcarbamoyl]-benzyl}-(1H-imidazol-2-ylmethyl)-carbamic acid t-butyl ester
  参考文献：
  名称：

  EP1550657

  摘要：

  公开号：
• 作为产物：
  描述：

  tert-butyl(4-(cyclohexyl(methyl)amino)butyl)carbamate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 以74 %的产率得到N1-cyclohexyl-N1-methyl-1,4-butanediamine
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS FOR TREATING A CYTOKINE-MEDIATED DISEASE
  [FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT D'UNE MALADIE À MÉDIATION PAR LA CYTOKINE

  摘要：

  The present invention relates to a compound of the following formula (I): in particular for use use in the diagnostic, prevention or treatment of a cytokine-mediated disease in an individual.

  公开号：

  WO2022101453A1

文献信息

• Amine compounds and use thereof
  申请人：Yamazaki Toru

  公开号：US20050165063A1

  公开（公告）日：2005-07-28

  It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.

  本发明旨在提供新型胺化合物，其对感染HIV病毒、风湿病和癌症转移等疾病具有疗效。即以下通式（1）所代表的胺化合物：在典型情况下，A1和A2分别代表可选择取代的单环或多环芳香杂环；W代表环状C3-10烷基，可选择取代的单环或多环芳香杂环，单环或多环芳香环或部分饱和多环芳香环；X代表O，CH2，C（═O）或NR11；D是以下通式（4）或（6）所代表的基团。在公式（6）中，Q代表单键，S，O或NR12；Y代表以下通式（7）所代表的基团。z代表可选择取代的单环或多环芳香环。在公式（6）中，B代表NR25R26。在上述公式中，R1至R26每个代表氢，烷基，烯基或炔基。
• Amine compound and use thereof
  申请人：Yamazaki Toru

  公开号：US20070208033A1

  公开（公告）日：2007-09-06

  It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.

  本发明旨在提供新型胺类化合物，其对诸如感染HIV病毒、风湿病和癌症转移等疾病具有疗效。具体来说，本发明提供以下通式（1）所表示的胺类化合物：其中，在典型情况下，A1和A2分别表示可选取代的单环或多环芳香杂环；W表示环状C3-10烷基，可选取代的单环或多环芳香杂环，单环或多环芳香环或部分饱和多环芳香环；X表示O、CH2、C（═O）或NR11；D是由以下通式（4）或（6）表示的基团。在公式（6）中，Q表示单键，S、O或NR12；Y是由以下通式（7）表示的基团。z表示可选取代的单环或多环芳香环。在公式（6）中，B表示NR25R26。在上述公式中，R1至R26分别表示氢、烷基、烯基或炔基。
• AMINE COMPOUND AND USE THEREOF
  申请人：YAMAZAKI Toru

  公开号：US20110046113A1

  公开（公告）日：2011-02-24

  It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(═O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). —(CR 18 R 19 )m 3 — Or —(CR 20 R 21 )m 4 -z-(CR 22 R 23 )m 5 (7) z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.

  旨在提供新型胺类化合物，对诸如感染HIV病毒、风湿病和癌症转移等疾病具有疗效。具体而言，是由以下通式（1）所代表的胺类化合物：在典型情况下，A1和A2各代表一个可选取的取代的单环或多环芳香杂环；W代表环状C3-10烷基，一个可选取的取代的单环或多环芳香杂环，一个单环或多环芳香环或部分饱和多环芳香环；X代表O，CH2，C（═O）或NR11；D是以下通式（4）或（6）所代表的基团。在通式（6）中，Q代表单键、S、O或NR12；Y是以下通式（7）所代表的基团。—（CR18R19）m3—或—（CR20R21）m4-z-（CR22R23）m5（7）z代表一个可选取的取代的单环或多环芳香环。在通式（6）中，B代表NR25R26。在上述式中，R1至R26各自代表氢、烷基、烯基或炔基。
• EP1550657
  申请人：——

  公开号：——

  公开（公告）日：——
• [EN] COMPOUNDS AND METHODS FOR TREATING A CYTOKINE-MEDIATED DISEASE<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT D'UNE MALADIE À MÉDIATION PAR LA CYTOKINE
  申请人：[en]CONSERVATOIRE NATIONAL DES ARTS ET MÉTIERS

  公开号：WO2022101453A1

  公开（公告）日：2022-05-19

  The present invention relates to a compound of the following formula (I): in particular for use use in the diagnostic, prevention or treatment of a cytokine-mediated disease in an individual.